High Grade Sarcoma: Clinical Trials

1 trial for High Grade Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow High Grade Sarcoma: new trials by email Literature Review of High Grade Sarcoma trials Research Report on High Grade Sarcoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
Pazopanib, Pazopanib Hydrochloride, Sapanisertib - High Grade Sarcoma, Metastatic Leiomyosarcoma
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)1512015-11-302022-08-23

Narrower conditions

Dermatofibrosarcoma (1)  ·  Histiocytoma, Malignant Fibrous (1)  ·  Leiomyosarcoma (1)  ·  Neurofibrosarcoma (1)  ·  Sarcoma, Synovial (1)

Broader conditions

Fibrosarcoma (1)  ·  Histiocytoma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Fibrous Tissue (1)  ·  Neoplasms, Muscle Tissue (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Nerve Sheath Neoplasms (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neurofibroma (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)

Interventions

pazopanib (1)  ·  sapanisertib (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

United States (1)

Top investigators

William D Tap (1)

NIH funding

U10CA180821 (1)